Mac Manus MP - Search Results

1

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.

Mac Manus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, Khaw P, Wirth A, Rischin D, McKenzie A. Mac Manus MP, et al. Cancer. 2001 Aug 15;92(4):886-95. doi: 10.1002/1097-0142(20010815)92:4<886::aid-cncr1397>3.0.co;2-v. Cancer. 2001. PMID: 11550162

2

Characteristics of 49 patients who survived for 5 years following radical radiation therapy for non-small cell lung cancer: the potential for cure.

Mac Manus MP, Wada M, Matthews JP, Ball DL. Mac Manus MP, et al. Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):63-9. doi: 10.1016/s0360-3016(99)00357-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 10656374

3

Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.

Kalff V, Hicks RJ, MacManus MP, Binns DS, McKenzie AF, Ware RE, Hogg A, Ball DL. Kalff V, et al. J Clin Oncol. 2001 Jan 1;19(1):111-8. doi: 10.1200/JCO.2001.19.1.111. J Clin Oncol. 2001. PMID: 11134203

4

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL. MacManus MP, et al. Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):287-93. doi: 10.1016/s0360-3016(01)01477-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11380213 Clinical Trial.

5

Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer.

Salminen E, Mac Manus M. Salminen E, et al. Ann Med. 2001 Sep;33(6):404-9. doi: 10.3109/07853890108995953. Ann Med. 2001. PMID: 11585101 Free article. Review.

6

Positron emission tomography in pulmonary masses where tissue diagnosis is unhelpful or not possible.

Pitman AG, Hicks RJ, Kalff V, Binns DS, Ware RE, McKenzie AF, Ball DL, MacManus MP. Pitman AG, et al. Med J Aust. 2001 Sep 17;175(6):303-7. doi: 10.5694/j.1326-5377.2001.tb143587.x. Med J Aust. 2001. PMID: 11665943

7

(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.

Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. J Nucl Med. 2001 Nov;42(11):1596-604. J Nucl Med. 2001. PMID: 11696627 Free article. Clinical Trial.

8

The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.

Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. J Nucl Med. 2001 Nov;42(11):1605-13. J Nucl Med. 2001. PMID: 11696628 Free article. Clinical Trial.

9

Exacerbation, then clearance, of mutation-proven Darier's disease of the skin after radiotherapy for bronchial carcinoma: a case of radiation-induced epidermal differentiation?

Mac Manus MP, Cavalleri G, Ball DL, Beasley M, Rotstein H, McKay MJ. Mac Manus MP, et al. Radiat Res. 2001 Dec;156(6):724-30. doi: 10.1667/0033-7587(2001)156[0724:etcomp]2.0.co;2. Radiat Res. 2001. PMID: 11741496

10

Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center.

Mac Manus MP, Wong K, Hicks RJ, Matthews JP, Wirth A, Ball DL. Mac Manus MP, et al. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):351-61. doi: 10.1016/s0360-3016(01)02673-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters